Surgisphere Corporation, a lesser-known health analytics company based in United States, was behind the research published in The Lancet which compelled the WHO to retract HCQ from the list of potential anti-coronavirus drugs. Several other countries were also compelled to change their policy over the drug, which has been regularly promoted by US President Donald Trump.